eubiOmic Health — Pre-seed (estimated) · €200K

eubiOmic Health, a biotech spin-off of the University of Granada and the Andalusian Public Health Service, closed its first investment round of €200,000 via a capital increase at a €1M pre-money valuation, backed by investment club Nazarí Ventures and a group of private investors. The company has developed the world's first food for special medical purposes for rectal cancer patients with an ileostomy, and the equity increase also unlocks favourable ENISA loan terms without further dilution.